Risperdal

Type: Product
Name: Risperdal
First reported 7 hours ago - Updated 4 hours ago - 1 reports

CDC Finds Up to 20% of U.S. Children Have Mental Health Disorders

As many as one in five individuals in the U.S. under age 18 experience a mental health disorder each year, and that rate is climbing, according to a CDC report released Thursday, the Washington Post reports.The report -- which is the first comprehensive ... [Published California Healthline - 7 hours ago]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

J&J, Up 25% YTD, Shrugs Off Risperdal Suits

Like a game of whack-a-mole, no matter how many times Johnson & Johnson (JNJ) attempts to put to rest lawsuits over the marketing of its Risperdal antipsychotic, another claim pops up. The latest is a lawsuit filed this week by the Kentucky attorney general, ... [Published Yahoo! Finance - May 17 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study

by Irina Vasilyeva, Robert G. Biscontri, Murray W. Enns, Colleen J. Metge, Silvia Alessi-SeveriniBackgroundDespite concerns over the potential for severe adverse events, antipsychotic medications remain the mainstay of treatment of behaviour disorders ... [Published Elites TV - May 17 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

RISPERDAL (Risperidone) Tablet [REMEDYREPACK INC. ]

Entities: Risperdal
First reported May 14 2013 - Updated May 14 2013 - 1 reports

RISPERDAL (Risperidone) Tablet [REMEDYREPACK INC. ]

Entities: Risperdal
First reported May 12 2013 - Updated May 12 2013 - 1 reports

Why I Love My Meds

Photo via Flickr user KleuskeThis past Monday I did a stand-up show, and one of the other comics said something along the lines of, “I have depression, but I recently stopped taking my medications.” The crowd applauded in support of her strength and ... [Published Vice Magazine US - May 12 2013]
First reported May 10 2013 - Updated May 10 2013 - 2 reports

J&J: Before We Hand Over That $2.2 Billion . . .

A much-anticipated settlement of various federal government probes into Johnson & Johnson (JNJ) marketing of the Risperdal antipsychotic, as well as other medications, is being delayed over language the health care giant fears may cause difficulties for ... [Published Yahoo! Finance - May 10 2013]
First reported May 10 2013 - Updated May 10 2013 - 1 reports

WSJ: J&J federal Risperdal deal hung up on language over breasts

Feds want side effects data in, J&J wants to avoid adding to civil litigation troublesShareToolsJohnson & Johnson ($JNJ) has been negotiating terms of a multi-billion dollar settlement over aggressive marketing of its antipsychotic drug Risperdal with ... [Published FiercePharma - May 10 2013]
First reported May 09 2013 - Updated May 10 2013 - 3 reports

WSJ: J&J Settlement With Justice Department On Hold Over Wording

Healthcare giant Johnson & Johnson's (JNJ: Quote) $2.2 billion settlement with the Justice Department last year regarding its sales practices is on hold, as the company seeks to avoid language in the agreement that may make it vulnerable to private lawsuits, ... [Published RTTNews.com - May 10 2013]
First reported May 09 2013 - Updated May 09 2013 - 1 reports

RISPERDAL (Risperidone) Tablet [REMEDYREPACK INC. ]

Entities: Risperdal
First reported May 07 2013 - Updated May 07 2013 - 1 reports

RISPERDAL (Risperidone) Tablet [REMEDYREPACK INC. ]

Entities: Risperdal
First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

New funding helps dementia patients on antipsychotic meds

· 11:33 AMWhen an 84-year-old SE Washington resident named Bob needed someone to advocate for him, the Long-Term Care Ombudsman Program, operated by Multi-Service Center in Federal Way, stepped in.Bob had been placed against his wishes into a nursing ... [Published Federal Way Mirror - Apr 25 2013]

Quotes

...But this means taking the DSM-5 apart and re-assembling it through arduous experimental work. "It’s going to take a decade or more for results to bear fruit" Cuthbert says
..."Teva should be encouraged by the existence of this product, because we have patented it," he said. "But I am not sure that they know how much progress we have made."
...I'd never worked directly with TBWA, but through the course of my conversations with them, I asked, "Hey, are there any ideas about what we should be doing?" And they had been noodling some ideas. At that point they'd showed me this idea that ultimately became "For All You Love...
...the New Drug Application NDA) for POSIDUR(TM) and look forward to the FDA's review," stated James E Brown, D V M , President and CEO of DURECT. "The FDA's recent decisions to allow updated labeling for opioids that demonstrate abuse-deterrent properties and not to allow generics against the original OxyContin® are positive developments for REMOXY®. Pfizer recently stated that they had a productive meeting with the FDA in late March and we note the recent additional patent issuance extending coverage of REMOXY in the U S to at least 2031. Another positive event during the first quarter was our collaborator Zogenix reporting positive results from the Relday(TM) Phase 1 study and rapid expansion of that study to include a higher dose, which today also reported positive results."

More Content

All (119) | News (84) | Reports (5) | Blogs (26) | Audio/Video (0) | Fact Sheets (2) | Press Releases (2)
sort by: Date | Relevance
CDC Finds Up to 20% of U.S. Children Have Menta... [Published California Healthline - 7 hours ago]
Alkermes Plc (ALKS) - Pharmaceuticals & Healthc... [Published TransWorldNews - May 18 2013]
Extractables and Leachables: Best Practices to ... [Published BioPharm International - May 18 2013]
J&J, Up 25% YTD, Shrugs Off Risperdal Suits [Published Yahoo! Finance - May 17 2013]
Movement Disorders in Elderly Users of Risperid... [Published Elites TV - May 17 2013]
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 15 2013]
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Why I Love My Meds [Published Vice Magazine US - May 12 2013]
J&J: Before We Hand Over That $2.2 Billion . . . [Published Yahoo! Finance - May 10 2013]
WSJ: J&J federal Risperdal deal hung up on lang... [Published FiercePharma - May 10 2013]
Will Male Breasts Derail a Johnson & Johnson (J... [Published BioSpace - May 10 2013]
WSJ: J&J Settlement With Justice Department On ... [Published RTTNews.com - May 10 2013]
J&J Settlement with Justice Department On Hold [Published Nasdaq - May 09 2013]
JOHNSON & JOHNSON : J&J Settlement with Justice... [Published 4 Traders - May 09 2013]
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
Alkermes' CEO Presents at Bank of America Merri... [Published Seeking Alpha - May 08 2013]
Why Psychiatry's Seismic Shift Will Happen Slowly [Published Forbes.com - May 08 2013]
Drug Marketing Blamed for Increase in ADHD Diag... [Published MedPage Today - May 08 2013]
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 07 2013]
Johnson & Johnson Hopes New 'Love' Campaign Wil... [Published Brandchannel.com - May 07 2013]
Teva rival develops delayed release Copaxone ve... [Published Globes - May 06 2013]
J&J Launches Massive Corporate-Image Rebranding... [Published Advertising Age - May 06 2013]
US probe ‘rules out’ negligence in Russian orph... [Published Voice of Russia - May 04 2013]
DURECT Corporation Announces First Quarter 2013... [Published Individual.com - May 02 2013]
Zogenix Reports Positive Top-Line Results From ... [Published Equities.com - May 02 2013]
Zogenix Reports Positive Top-Line Results From ... [Published Street Insider - May 02 2013]
‘He will have a great future’: doctor [Published Inside Toronto - May 01 2013]
First Manhattan Files Preliminary Proxy Materia... [Published Daily Finance - May 01 2013]
First Manhattan Responds to VIVUS Board Additio... [Published Equities.com - May 01 2013]
First Manhattan Responds to VIVUS Board Additio... [Published Benzinga.com - May 01 2013]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 15 2013]
Updated Date: May 15, 2013 EST ...
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Updated Date: May 7, 2013 EST ...
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
Updated Date: May 7, 2013 EST ...
RISPERDAL (Risperidone) Tablet [REMEDYREPACK IN... [Published DailyMed Drug Label Updates for the last seven ... - May 07 2013]
Updated Date: May 7, 2013 EST ...
RISPERIDONE (Risperidone ) Tablet [Apotex Corp] [Published DailyMed Drug Label Updates for the last seven ... - Apr 03 2013]
Updated Date: Apr 3, 2013 EST ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Study Suggests Some Antipsychotics Unsafe for E... [Published CisionWire - English - Dec 05 2012]
Breckenridge announces agreement with Ajanta Ph... [Published PR Newswire - Oct 03 2012]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.